Biotech company Geron Corp. agreed to provide stem cells to General Electric Co.'s GE Healthcare for use in tools that will test for the toxic effects of drug treatments, a move that takes GE further into stem-cell research.
The agreement marks the first time that a company of GE's stature and size has announced a business venture involving the controversial field of embryonic stem...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to GE to Obtain Stem Cells From Geron For Research
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account